The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Vaxxinity, Inc.(NASDAQ:VAXX) 
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease; UB-...
Website: http://www.vaxxinity.com
Founded: 2019
CEO: Mei Mei Hu
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
Vaxxinity . Days Payable Outstanding ttm (DPO)
Vaxxinity . Days Receivable Outstanding ttm (DSO)
Vaxxinity . Days Inventory Outstanding ttm (DIO)
Vaxxinity . Op Cashflow Per Share ttm
Vaxxinity . Free Cashflow Per Share ttm
Vaxxinity . Cash Per Share ttm
Vaxxinity . P/S ratio ttm
Vaxxinity . (GAAP) P/E ratio ttm
Vaxxinity . P/B ratio ttm
No extra charts and metrics for this ticker.